Infections and illnesses in children with Bb E beta-thalassemia: a prospective controlled study

Area of Science:

• Hematology
• Pediatric Infectious Diseases
• Genetics

Background:

• Hemoglobin E beta-thalassemia is a genetic blood disorder requiring ongoing management.
• Infections pose a significant risk to pediatric patients with chronic illnesses, particularly those with beta-thalassemia.
• Splenectomy, a common procedure in severe cases, can alter infection susceptibility.

Purpose of the Study:

• To prospectively evaluate and compare the incidence of infections and illnesses in pediatric patients with severe and non-severe Hb E beta-thalassemia against a control group.
• To investigate the potential impact of disease severity and management strategies on infection rates.

Main Methods:

• A 3-year prospective, controlled follow-up study involving 50 severe Hb E beta-thalassemia patients, 24 non-severe Hb E beta-thalassemia patients, and 24 healthy sibling controls.
• Participants reported illnesses and treatments bi-weekly via postcards over a median follow-up of 32.5-35.5 months.
• Infection rates per 1000 patient-months were calculated and compared between the three groups.

Main Results:

• No significant difference in the overall rate of infections per 1000 patient-months was observed between severe Hb E beta-thalassemia patients, non-severe Hb E beta-thalassemia patients, and controls.
• This finding persisted despite 52% of severe patients having undergone splenectomy.
• The study suggests that regular blood transfusions and iron chelation therapy might play a role in mitigating infection risk.

Conclusions:

• Pediatric patients with Hb E beta-thalassemia do not exhibit a significantly higher infection rate compared to healthy controls, even in severe cases or post-splenectomy.
• Effective management strategies, including regular blood transfusions and iron chelation, may be crucial in preventing infections in this vulnerable population.